Radiation Dose Management Market to Increase Exponentially During 2015-2021

Radiation is energy emitted as a particle or wave that comes from a source and travels through some material or through space. Radiation dose is an amount of radiation energy absorbed by the body. It can be measured in a number of ways. Absorbed dose, effective dose, and equivalent dose are some of the forms of radiation dose. Absorbed dose is the concentration of energy deposited on the tissue, as a result of an exposure to ionizing radiation and is used to assess the potential for biochemical changes in specific tissues. Equivalent dose is used to assess the expected amount of biological damage caused by the absorbed dose. Similarly, the amount of effective dose depends on factors such as absorbed dose by all organs of the body and sensitivity of each organ to radiation. Radiation dose has its application in radiotherapy, mammography, computed tomography, nuclear medicine, fluoroscopy, and interventional imaging. It is used in hospitals, clinics, research centers, diagnostic centers, and academic medical centers.

North America dominates the global market for radiation dose management due to stringent regulations for patient safety and patient care and increasing risks and incidences of chronic disorders in the region. Asia Pacific is expected to exhibit a high growth rate in the next five years in the global radiation dose management market, with China and India being the fastest-growing markets in Asia Pacific.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4756

The key driving forces for the radiation dose management market in developing countries are the large pool of patients, increasing awareness among patients, rising number of multi-specialty hospitals, rising investment by government and private entities to adopt health care IT technologies, rise in medical tourism, improving health care infrastructure, rising government initiatives for e-health, and growing health care expenditure in the region.

Increasing demand for patient safety and improved health care services; rising awareness about radiation safety among patients, physicians, and technicians; rise in various dose management campaigns across the globe for increasing patient safety, and growing risk and incidences of chronic diseases are driving the growth of the global radiation dose management market. In addition, rising adoption of electronic health records, compliance obligations of health care providers with stringent state and federal laws, and increasing awareness and knowledge among patients regarding the consequences of extended radiation exposure, are fueling the growth of the global radiation dose management market.

In addition, increasing need to cut radiation dose levels owing to the risks of serious disorders caused due to exposure to harmful radiations, increasing usage of computed tomography for the diagnosis of various diseases, increasing health care expenditure, and rising health care awareness are some of the key factors driving the growth of the global radiation dose management market. However, lack of funding, ignorance of technicians and physicians in health care organizations toward risks associated with radiation exposure, and lack of standard protocols, act as major restraints for the growth of the global radiation dose management market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4756

Increased use of interventional imaging and nuclear medicine in medical imaging, and technological advancements in radiation dose management systems are expected to create opportunities for the global radiation dose management market.

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here @ https://www.persistencemarketresearch.com/checkout/4756

Human Augmentation Market To Collect Hugh Revenues Due To Growth In Demand by 2021

Human augmentation, also known as Human 2.0, refers to technologies that are used for bringing physical improvement in the integral parts of the human body. Technological advancements in IT have led to the introduction of a greater variety of implants and other technologies, which are used for human augmentation. In addition, genetic engineered human technologies also play an important role in the treatment of various diseases and disabilities.

The global human augmentation market is categorized based on various types of products and applications. Based on products, the report covers wearable augmentation products and in-built augmentation products. The wearable augmentation product segment accounts for the largest market share in the global human augmentation market. The wearable augmentation product segment is further sub-segmented into eye-wear, wrist-wear, neck-wear, foot-wear, body-wear, and others. Major eye-wear products include smart contact lenses, Helmet-Mounted Display (HMD), Head-Up Display (HUD), and Google glass. The wrist-wear sub-segment is further sub-divided into wrist bands and watches. Major neck-wear products include ties and collars and ornaments and precious metals. The body-wear sub-segment is further sub-segmented into arm and leg wear and clothing and innerwear. Other category includes smart headsets, smart socks, and smart rings. Eye-wear and wrist-wear sub-segments hold the largest market share in the global human augmentation market. Based on applications, the report covers health care, industrial, and defense industries.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4463

In terms of geography, North America dominates the global human augmentation market. This is due to the improved economy and increasing demand for augmentation products in the region. In addition, technological advancements in medical wearable products have also propelled the growth of the market in North America. The U.S. represents the largest market for human augmentation in North America, followed by Canada. In Europe, Germany, France, and the U.K. account for major shares of the human augmentation market. The human augmentation market in Asia is also expected to witness high growth rates in the next five years. This is due to the increasing innovative applications of augmentation products and rising awareness about therapeutic applications of the medical wearable augmentation products in the region. Rising demographics and economies in developing countries, such as India and China, are expected to lead to the growth in the human augmentation market in Asia. Moreover, India, China, and Japan, are expected to be the fastest growing markets for human augmentation products in the region.

Increasing demand for wearable augmentation products and rising awareness about therapeutic applications of medical wearable products are some of the major driving factors of the global human augmentation market. Also, technological advancements witnessed in sensor technologies have further propelled the growth of the global human augmentation market.

Lack of skilled IT professionals and high cost of equipment are the major restraints for the global human augmentation market. In addition, imposition of stringent regulations for the approval of augmentation devices as well as the related legal and social concerns inhibits the growth of the market. Rapid product launches and increasing number of mergers and acquisitions between various health care IT companies are some of the major trends observed in the global human augmentation market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4463

The major companies operating in this market are

Second Sight Medical Products
B-Temia Inc.
Vuzix Corporation
Braingate Company
Samsung Electronics Co. Ltd.
Ekso Bionics Holdings
Rewalk Robotics Ltd.
Google Inc.
Raytheon Company
Magic Leap

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here

Medical Gloves Market to Hold a High Potential for Growth by 2021

Medical gloves are gloves that one use gloves and should preferably be disposed of after just one use specially when dealing with bacterial culture or worn during surgeries. These gloves are manufactured out of various kinds of polymers including latex, nitrile rubber, vinyl and neoprene. These products are available either in the powdered or in the non-powdered form or are powdered with cornstarch to lubricate them so that it becomes easier for one to put on. Before the usage of cornstarch, tissue irritating Lycopodium powder and talc was used. After which it was discovered that even cornstarch would impede healing especially during surgeries, hence non-powdered gloves were preferred during surgeries.

There are 2 types of medical gloves, exam gloves and surgical gloves. Surgical gloves, which are used during surgeries, are usually made to a higher standard and have more precise sizing, better precision and sensitivity, while exam gloves are available as either sterile glovers orf non-sterile gloves. Surgical gloves are always available as sterile gloves. These gloves have multiple purposes in the medical world right from surgical purposes to dental applications. These gloves are also used during commission of crimes due to their thinness and tight fit, which allows dexterity.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4647

Latex, which is used in the production of these gloves s being replaced by vinyl, nitrile rubber or neoprene, is widely used, as there is increasing rate of latex allergy among general population. Latex was used as a raw material as it was cheaper, the high grade nitrile gloves that are available nowadays is double the price of latex. This is one of the reasons, cost effective environments like hospitals have not replaced latex gloves yet.

The main factors that drive the medical drive market is the growing awareness of health and safety measures that have to be employed in order to stop spread of diseases. Patients and health medics have recognized the increasing need for gloves globally. Disposable gloves have served the medical industry for a long time in terms of hygiene maintenance, safety measures and low cost. The non powdered glove market is expected to grow at a faster rate due to its use in surgery as compared to powdered gloves which retards the healing process. The healthcare and the medical industry is growing at a fast rate thus increasing the growth of disposable gloves market as it is the staple product required in this industry. However, the prices of raw materials keep fluctuating and currency fluctuations create complications for this market.

The key segments for the medical gloves industry include North America, Europe, Asia Pacific and Rest of the World (RoW). The U.S. is said to be largest market for disposable medical gloves while the Asia Pacific countries are known to be the fastest growing market in this sector. The developing healthcare industry is boosting the growth of these disposable gloves in the emerging countries. The fast growth in the food processing, personal care, hygiene and medical industries are the major factors that enhance the growth of these gloves in North America. Europe follows North America concerning the usage of medical disposable gloves but the rapidly growing healthcare industry in developing countries is expected to increase thus decreasing the glove market share in Europe. These segments focus mainly on the production and manufacture of non-powdered gloves as the market for powdered gloves is decreasing owing to the fact that it retards the healing process.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4647

The key companies profiled for the manufacture of medical disposable gloves include

Ansell Healthcare
Hartalega Holdings
Supermax Corporation Berhad
Kossan Rubber Products
Rubberex

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here @ https://www.persistencemarketresearch.com/checkout/4647

Molecular Diagnostics Infectious Disease Testing Market to Boom in Near Future by 2021 Industry Key Players

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

The global molecular diagnostics in infectious disease testing market is categorized based on product, application, technique, and end user. Based on product, the report covers instruments and analyzers, assays and reagents, and services and softwares. Based on application, the market comprises hepatitis B, hepatitis C, AIDS, TB, methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired infections, Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV) infection, and others. Based on technique, the market covers polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), microarrays, next-generation sequencing (NGS), hybridization, and others. Based on end user, the market comprises hospitals, private labs, clinics, academic institutes, laboratories, and others.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4427

North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.

Technological advancement in diagnostic procedures for infectious diseases, the increasing prevalence of infectious diseases, a growing elderly population, and the growth of research activities in molecular diagnostic technologies are some major drivers for the global molecular diagnostics in infectious disease testing market. Moreover, government support in the form of funding for the diagnosis and prevention of infectious diseases is also supporting the growth of the global molecular diagnostics in infectious disease testing market. However, the high cost of instruments involved in molecular diagnostic technologies and the lack of skilled healthcare professionals are some major restraints on the growth of the market.

Increasing numbers of mergers and acquisitions and rapid product launches are some of the latest trends that have been observed in the global molecular diagnostics in infectious disease testing market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4427

Some of the major companies operating in the global molecular diagnostics in infectious disease testing market are

Abbott Laboratories
Becton
Dickinson and Company
bioMérieux
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Siemens AG
Veridex
Luminex Corp.
GenMark Diagnostics
Qiagen N.V.
Genomix Biotech
bioTheranostics.

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here @ https://www.persistencemarketresearch.com/checkout/4427

Molecular Weight Marker Market to 2021 with Patents and Expiry Dates for Major Products by Leading Suppliers

Molecular weight markers are used to calculate sample molecular weights in the medical research arena. In addition, these markers play a vital role in the monitoring of the progress of an electrophoretic run in separation and analysis of macromolecules. Molecular weight markers include RNA, DNA, and protein markers.

The global molecular weight market is categorized on the basis of applications, products, end users, and staining procedures. Based on the type of applications, the report comprises protein and nucleic acid applications. The protein application segment is further subsegmented into gel extraction and Western blotting applications. Protein application is the fastest-growing segment in the molecular weight marker market. Nucleic acid applications include polymerase chain reaction (PCR), Northern blot, sequencing, molecular cloning, and Southern blot. The nucleic acid segment holds the largest market share in the global molecular weight marker market.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4385

On the basis of product, the report covers protein and RNA and DNA markers. These products are categorized on the basis of their marker sizes. The protein and RNA markers sizes included in the report are below 10 kilo Dalton (kDa), 10 kDa to 100 kDa, 100 kDa to 200 kDa, and above 200 kDa markers. The DNA markers sizes included in the report are below 50 base pair (bp), 50 bp to 100 bp, 100 bp to 1 kilo base pair (kb), 1 kb to 5 kb, and above 5 kb.

On the basis of end user, the global molecular weight marker market report is segmented into biotechnology and pharmaceutical companies, academic research institutes, and contract research organizations. The staining segment is further subsegmented into unstained, prestained, and specialty markers.

In terms of geography, North America dominates the global molecular weight marker market. This is due to increased awareness about therapeutic applications of molecular biomarkers in disease management in the region. In addition, improved life science infrastructure has also propelled the growth of the molecular weight marker market in the region. The U.S. represents the largest market for molecular weight markers in North America, followed by Canada. In Europe, Germany, France, and the U.K. hold major shares of the molecular weight marker market. The molecular weight marker market in Asia too, is expected to show high growth rates in the next five years. This is due to the proliferation of biotechnology companies setting up manufacturing facilities in the region. Moreover, the growing life science infrastructure is also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest-growing markets for molecular weight markers in Asia.

The increasing prevalence of chronic diseases that require molecular biomarkers for their treatment is a key driver of the global molecular weight marker market. In addition, increasing government supports in the form of funding in the life science arena is also supporting the growth of the global molecular weight marker market. Increasing investment in R&D in biotechnology and pharmaceutical sectors and innovative applications of molecular weight markers have fueled the growth of this market. However, lack of skilled healthcare professionals obstructs the growth of the global molecular weight marker market.

Increasing numbers of mergers and acquisitions between biotechnology and pharmaceutical companies is a key trend of the global molecular weight marker market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4385

The major companies operating in this market are

Bio-Rad Laboratories
Agilent Technologies
F. Hoffmann-La Roche Ltd.
Takara Bio
Qiagen N.V.
Promega Corporation
New England Biolabs
Affymetrix
Thermo Fisher Scientific
Sigma-Aldrich Corporation.

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here @ https://www.persistencemarketresearch.com/checkout/4385

Drug Eluting Balloons Market SWOT Analysis by Key Players Forecast to 2015 to 2021

Coronary artery disease is a very common type of heart disease. It occurs when the arteries that supply blood to the heart muscle harden and become narrow owing to the buildup of cholesterol and other materials on their inner walls. This results in insufficient blood and oxygen flow through the arteries to the heart muscle, hampering its normal functioning. This can lead to chest pain and heart attack. The major reason behind a heart attack is the sudden discontinuation of blood supply to the heart, which permanently damages the organ. Coronary artery diseases also weaken the heart muscle and contribute to heart failure and arrhythmias.

Drug-eluting balloons play a vital role in the treatment of coronary artery disease. A drug-eluting balloon is an emerging device that optimizes clinical outcomes in coronary artery diseases. It becomes a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularization through stent technologies.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4228

The global drug-eluting balloons market is categorized on the basis of therapeutic application of this device in the treatment of various coronary artery diseases and peripheral artery diseases. Based on coronary artery diseases, the report covers in-stent restenosis, lesions in tortuous vessels, bifurcation lesions, and acute myocardial infarction. Based on peripheral artery diseases, the report comprises femoral/popliteal lesions and below knee lesions.

In terms of geography, North America dominates the global drug-eluting balloons market. This is due to increasing prevalence of coronary artery diseases in the region. The U.S. represents the largest market for drug-eluting balloons in North America, followed by Canada. In Europe, Germany, France, and the U.K. hold major shares of the drug-eluting balloons market. The drug-eluting balloons market in Asia is expected to show high growth rates in the next five years. This is due to various initiatives undertaken by governments to increase awareness about therapeutic applications of drug-eluting balloons in coronary and peripheral artery diseases. In addition, aging population and increased investments by many foreign medical device companies have also propelled the growth of the drug-eluting balloons market in the region. India, China, and Japan are expected to be the fastest growing markets for drug-eluting balloons in Asia.

Elderly people are more susceptible to cardiovascular diseases compared to adults. According to UN reports_bk_01_01_2020, approximately 30% of the total population in China will comprise elderly people by 2050. Developing countries, such as India and China, are expected to have a larger geriatric population base compared to developed countries, such as the U.S. For instance, the number of people aged above 60 years is expected to reach 437 million in China and 324 million in India compared to 107 million in the U.S. by 2050.

Increasing aging population, rising obesity, and increasing prevalence of coronary artery diseases are key drivers for the global drug-eluting balloons market. Also, advanced applications of drug-eluting balloons and increased government support in the form of funding and research has fueled the growth of this market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4228

Increasing number of mergers and acquisitions of medical devices manufacturing companies and rapid product launches are key trends of the global drug-eluting balloons market.

The major companies operating in this market are

B. Braun Melsungen AG
C.R. Bard
Aachen Resonance GmbH
Eurocor GmbH
Medtronic
Cook Medical

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here @  https://www.persistencemarketresearch.com/checkout/4228

Patient Engagement Solutions Market SWOT analysis & Key Business Strategies by key players 2021

Patient engagement solutions help patients manage their healthcare information and allows for greater interataction of the medical team with the patients. It is essential for to provide the necessary tools to actively engage in the management of their own health. Better access to healthcare providers and personal healthcare information helps patients to assists effective self-care. Cost-effective healthcare, increased patient outreach, fewer complications, lower hospital readmission rates, shorter hospitalization periods, and improved quality of health care are some of the benefits associated with patient engagement solutions. It shares information and communication to support patient and to improve workflow efficiencies. Moreover, it helps to reduce administrative costs. Patient engagement solutions enhance patient-provider communication and keeps both the patient and care team up to date about the individual health data. Healthcare organizations must improve quality and efficiency with few resources with the help of the solution. It assists physicians in providing better diagnosis and more coordinated care by recording information about patients’ healthcare and also allows for the sharing of clinical summaries among care teams. There is growing interest among patients to track theirpersonal health by accessing electronic health records. Moreover, the growing trend of mobile health applications and wearable health data trackers are influencing consumers to access their personal healthcare records, in turn, increasing demand for patient engagement solutions.

For detailed insights on enhancing your product footprint, request for a Sample here @ https://www.persistencemarketresearch.com/samples/4221

North America dominates the global market for patient engagement solutions due to rising chronic diseases, regulatory mandates by Affordable Care Act, increasing demand for quality care, rising healthcare costs, and rise in geriatric population in the region. Asia is expected to show high growth rates over the next five years in the global patient engagement solutions market. China and India are anticipated to be the fastest growing markets in the Asia-Pacific region. The key driving forces for the market in developing countries are the large pool of patients, increasing awareness about diseases, rising healthcare costs, improving healthcare infrastructure, increasing healthcare information technology adoption, and growth of medical tourism in these regions.

Implementation of Affordable Care Act, increasing popularity of mobile health applications, rise in number of accountable care organizations, rise in geriatric population, increasing prevalence of chronic diseases, rise in number of accountable care organizations, federal mandate encouraging the use of patient engagement solutions among stake holders, increase in healthcare expenditure, demand for good quality of care, enhanced worker productivity, incentives by various governments for the adoption of patient engagement, and advanced information technology and large data capabilities are some of the key factors driving the growth of the global patient engagement solutions market. However, lack of skilled analysts, subpar infrastructure, requirement for infrastructural investments, lack of health literacy in large portion of population, poor access to healthcare, lack of security of patient data and health information safety concerns are major restraints on the growth of the global patient engagement solutions market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/4221

Cloud-based models of patient engagement solutions and increasing medical tourism are expected to help develop opportunities for the global patient engagement solutions market in the future. Major companies operating in the global patient engagement solution market are

Medecision
Orion Health group of companies
Emmi Solutions
Allscripts Healthcare Solutions
Mckesson Corporation
Aetna
Cerner Corporation
athenahealth
GetWellNetwork

Reasons to Purchase this Report:

Accuracy and Quality

Our reports strive to offer superior quality reports based on authentic and accurate findings.

Customer Satisfaction

We aim to ensure that our client’s research needs are met with customized, top-of-the-line solutions.

Unmatched Expertise

Our analysts and consultants are among the best in their field and promise to deliver excellent market intelligence.

360-degree Analysis

We leave no stone unturned to give clients an exhaustive coverage of the industry.

For in-depth competitive analysis, Check Pre-Book here @ https://www.persistencemarketresearch.com/checkout/4221